Panbela Therapeutics, Inc.
PBLA · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25,263 | -$34,933 | -$10,135 | -$4,768 |
| Dep. & Amort. | $0 | $0 | $0 | $114 |
| Deferred Tax | $0 | $0 | $0 | -$114 |
| Stock-Based Comp. | $823 | $1,088 | $1,287 | $1,205 |
| Change in WC | -$647 | $559 | $2,144 | -$188 |
| Other Non-Cash | -$162 | $18,010 | $0 | -$103 |
| Operating Cash Flow | -$25,249 | -$15,276 | -$6,704 | -$3,854 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$660 | $0 | $0 |
| Net Acquisitions | $400 | $4 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$540 | $0 |
| Investing Cash Flow | $400 | -$656 | -$540 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,650 | $0 | $0 | -$757 |
| Stock Issued | $23,053 | $5,349 | $9,054 | $11,081 |
| Stock Repurch. | -$10 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4,749 | $5 | $1,041 | $120 |
| Financing Cash Flow | $26,142 | $5,354 | $10,095 | $10,444 |
| Forex Effect | $0 | -$4 | -$6 | -$17 |
| Net Chg. in Cash | $1,293 | -$10,582 | $2,845 | $6,573 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,285 | $11,867 | $9,022 | $2,449 |
| End Cash | $2,578 | $1,285 | $11,867 | $9,022 |
| Free Cash Flow | -$25,249 | -$15,936 | -$6,704 | -$3,854 |